← Back to Patent Explorer
US5832932A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of treating movement disorders by brain infusion

Assignee: Medtronic Inc
•
Filing: 1997-04-30
•
Granted: 1998-11-10
•
Expires: 2017-04-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is directed to techniques and apparatus for infusing drugs into the brain to treat movement disorders resulting in abnormal motor behavior. The invention employs an implantable pump and a catheter, the catheter having a proximal end coupled to the pump and a discharge portion for placement adjacent a predetermined infusion site in the brain for infusing therapeutic dosages of the one or more drugs into the brain. The pump is operated to discharge a predetermined dosage of the one or more drugs through the discharge portion of the catheter into the infusion site. A sensor may be used in combination with the implantable pump and catheter, whereby the sensor generates a signal relating to the extent of the abnormal motor behavior. The therapeutic dosage is regulated so that the dosage is adjusted in response to an increase in the abnormal behavior to decrease the abnormal motor behavior.

Inventors

  • 👤 Dennis D. Elsberry
  • 👤 Mark T. Rise
  • 👤 Scott R. Ward

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 22:12
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/142; A61M5/14244; A61M5/14276; A61M5/168; A61M5/172; A61M5/1723; A61M2202/00; A61M2202/04; A61M2202/0464; A61M2210/00; A61M2210/06; A61M2210/0693

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 147 words
A method of using one or more drugs to treat a movement disorder resulting in abnormal motor behavior by means of an implantable pump and a catheter having a proximal end coupled to said pump and a discharge portion for infusing therapeutic dosages of said one or more drugs comprising the steps of: surgically implanting said catheter in the brain so that the discharge portion lies adjacent to a predetermined infusion site in the brain wherein said predetermined infusion site is selected from the group consisting of ventrolateral thalamus (Thal), internal segment of globus pallidus (GPi), substantia nigra pars reticulata (SNr), subthalamic nucleus (STN), external segment of globus pallidus (GPe), striatum, and neostriatum; and operating said pump to discharge a predetermined dosage of said one or more drugs through said discharge portion of said catheter into said infusion site, whereby said abnormal motor behavior is therapeutically treated.
Claim 2
Independent Claim 147 words
A method of using one or more drugs to treat a movement disorder resulting in abnormal motor behavior by means of an implantable pump and a catheter having a proximal end coupled to said pump and a discharge portion for infusing therapeutic dosages of said one or more drugs comprising the steps of: surgically implanting said catheter in the brain so that the discharge portion lies adjacent to a predetermined infusion site in the brain wherein said predetermined infusion site is selected from the group consisting of ventrolateral thalamus (Thal), internal segment of globus pallidus (GPi), substantia nigra pars reticulata (SNr), subthalamic nucleus (STN), external segment of globus pallidus (GPe), striatum, and neostriatum; and operating said pump to discharge a predetermined dosage of said one or more drugs through said discharge portion of said catheter into said infusion site, whereby said abnormal motor behavior is therapeutically treated.
Claim 3
Dependent Claim 25 words
A method, as claimed in claim 1, wherein said movement disorder is a hyperkinetic disorder; and wherein said drugs are selected to reduce thalamic output.
Claim 4
Dependent Claim 20 words
A method, as claimed in claim 2, wherein said hyperkinetic disorder comprises Huntington's disease, amyotrophic lateral sclerosis, ballism, or dystonia.
Claim 5
Dependent Claim 24 words
A method, as claimed in claim 2, wherein said one or more drugs decrease excitement of the thalamus or increase inhibition of the thalamus.
Claim 6
Dependent Claim 37 words
A method, as claimed in claim 4, wherein said one or more drugs decrease inhibition or increase excitation of said internal segment of globus pallidus (GPi) or said substantia nigra pars reticulata (SNr) that inhibit thalamic output.
Claim 7
Dependent Claim 45 words
A method, as claimed in claim 5, wherein said one or more drugs are selected from the group consisting of a glutamate antagonist, a glutamate agonist, a γ-aminobutyric acid (GABA) antagonist, a γ-aminobutyric acid (GABA) agonist, a dopamine (DA) antagonist and a dopamine (DA) agonist.
Claim 8
Dependent Claim 25 words
A method, as claimed in claim 1, wherein said movement disorder is a hypokinetic disorder; and wherein said drugs are selected to increase thalamic output.
Claim 9
Dependent Claim 14 words
A method, as claimed in claim 7, wherein said hypokinetic disorder comprises Parkinson's disease.
Claim 10
Dependent Claim 24 words
A method, as claimed in claim 7, wherein said one or more drugs increase excitement of the thalamus or decrease inhibition of the thalamus.
Claim 11
Dependent Claim 37 words
A method, as claimed in claim 9, wherein said one or more drugs increase inhibition or decrease excitation of said internal segment of globus pallidus (GPi) or said substantia nigra pars reticulata (SNr) that inhibit thalamic output.
Claim 12
Dependent Claim 45 words
A method, as claimed in claim 10, wherein said one or more drugs are selected from the group consisting of a glutamate antagonist, a glutamate agonist, a γ-aminobutyric acid (GABA) antagonist, a γ-aminobutyric acid (GABA) agonist, a dopamine (DA) antagonist and a dopamine (DA) agonist.
Claim 13
Independent Claim 125 words
A method of using one or more drugs to treat a movement disorder resulting in abnormal motor behavior by means of an implantable pump and a catheter having a proximal end coupled to said pump and a discharge portion for infusing therapeutic dosages of at least one drug comprising the steps of: surgically implanting said catheter in the brain so that the discharge portion lies adjacent to a predetermined infusion site in the brain; and implanting an implantable sensor for generating a signal for detecting the extent of abnormal motor behavior and for signaling said pump to discharge a dosage of said at least one drug through said discharge portion of said catheter into said infusion site, whereby said abnormal motor behavior is therapeutically treated.
Claim 14
Independent Claim 125 words
A method of using one or more drugs to treat a movement disorder resulting in abnormal motor behavior by means of an implantable pump and a catheter having a proximal end coupled to said pump and a discharge portion for infusing therapeutic dosages of at least one drug comprising the steps of: surgically implanting said catheter in the brain so that the discharge portion lies adjacent to a predetermined infusion site in the brain; and implanting an implantable sensor for generating a signal for detecting the extent of abnormal motor behavior and for signaling said pump to discharge a dosage of said at least one drug through said discharge portion of said catheter into said infusion site, whereby said abnormal motor behavior is therapeutically treated.
Claim 15
Dependent Claim 29 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense motion behavior of a portion of a body.
Claim 16
Dependent Claim 30 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense abnormal movement behavior of a portion of a body.
Claim 17
Dependent Claim 23 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense gravity direction.
Claim 18
Dependent Claim 26 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense motion relative to an object.
Claim 19
Dependent Claim 23 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense muscle EMG.
Claim 20
Dependent Claim 23 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense brain EEG.
Claim 21
Dependent Claim 25 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense nerve compound action potentials.
Claim 22
Dependent Claim 25 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense posture of a patient.
Claim 23
Dependent Claim 24 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense nerve cell activity.
Claim 24
Dependent Claim 26 words
A method, as claimed in claim 12, wherein the step of implanting including the step of positioning said sensor to sense electrical activity in a thalamus.
Claim 25
Dependent Claim 25 words
A method, as claimed in claim 12, further comprising the step of implanting said pump to discharge a dosage of said at least one drug.
Claim 26
Dependent Claim 23 words
A method, as claimed in claim 12, further comprising the step of implanting a drug administration device containing said at least one drug.
Claim 27
Dependent Claim 40 words
A method, as claimed in claim 12, further comprising the step of implanting a drug administration device containing said at least one drug and a microprocessor for regulating said pump to discharge a dosage of said at least one drug.

References Cited (Backward Citations)

US3957036A Cited
US4692147A Cited
WO1985001213A1 Cited
US5011472A Cited
US5458631A Cited
US5474547A Cited
US5119832A Cited
US5031618A Cited
US5293879A Cited
US5423877A Cited
WO1994001166A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-11-09 2002-05-11 2002-11-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-11-09 2006-05-11 2006-11-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-11-09 2010-05-11 2010-11-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag